Kate Therapeutics
Ana Maria Manso-Martin is currently employed as a Principal Scientist at Kate Therapeutics. Prior to this role, Ana Maria held the position of Assistant Project Scientist at the University of California, San Diego - School of Medicine.
This person is not in any offices
Kate Therapeutics
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.